These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4151960)

  • 1. [The development of research on circulatory pharmacology in Hungary during the past 25 years].
    Szekeres L
    Orv Hetil; 1974 Jan; 115(2):63-9. PubMed ID: 4151960
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in cardiovascular pharmacology.
    Lucchesi BR
    AANA J; 1974 Oct; 42(5):419-38. PubMed ID: 4155586
    [No Abstract]   [Full Text] [Related]  

  • 3. Fifty years of beta-adrenergic blockade: a golden era in clinical medicine and molecular pharmacology.
    Frishman WH
    Am J Med; 2008 Nov; 121(11):933-4. PubMed ID: 18954835
    [No Abstract]   [Full Text] [Related]  

  • 4. [Receptor pharmacology (4): beta adrenoreceptor blocker effect in cardiovascular diseases].
    Carlsson E; Ablad B
    Lakartidningen; 1978 Nov; 75(44):4028-33. PubMed ID: 30000
    [No Abstract]   [Full Text] [Related]  

  • 5. Atenolol is dead: long live beta-blockade.
    Cockcroft JR
    J Am Coll Cardiol; 2009 Jun; 53(22):2102; author reply 2106-7. PubMed ID: 19477365
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combined effect of beta-adrenoblockaders with other pharmacologic agents (review of the literature)].
    Gorodinskaia VIa
    Vrach Delo; 1971 Apr; 7():4-9. PubMed ID: 4400881
    [No Abstract]   [Full Text] [Related]  

  • 7. [General principles of the use of inhibitors of adrenergic receptors].
    Mornex R
    Cah Med; 1974 Nov; 15(13):817-28. PubMed ID: 4155996
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta blockers as cardioprotective agents: Part II--Focus on prevention of sudden cardiac death.
    Goldstein S
    Am J Manag Care; 2002 Jun; 8(9 Suppl):18-24. PubMed ID: 12099324
    [No Abstract]   [Full Text] [Related]  

  • 9. [Future development of sympathetic nervous system blockaders].
    Sakanashi M
    Nihon Rinsho; 1985 May; 43(5):995-9. PubMed ID: 2863404
    [No Abstract]   [Full Text] [Related]  

  • 10. Major research events in pharmacology, 1940-1970.
    Koelle GB
    Fed Proc; 1971; 30(4):1408-12. PubMed ID: 4934052
    [No Abstract]   [Full Text] [Related]  

  • 11. [Resp-informations].
    Bouvier-Colle MH; Cot M; Le Goaster C
    Rev Epidemiol Sante Publique; 2000 Apr; 48(2):215-24. PubMed ID: 10804430
    [No Abstract]   [Full Text] [Related]  

  • 12. Are new antihypertensive agents better than old antihypertensive agents in preventing cardiovascular complications?
    Dickerson LM; Carek PJ
    J Fam Pract; 2002 Jan; 51(1):9. PubMed ID: 11927051
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-blockers as first-line antihypertensive therapy the crumbling continues.
    Lavie CJ; Messerli FH; Milani RV
    J Am Coll Cardiol; 2009 Sep; 54(13):1162-4. PubMed ID: 19761937
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenergic receptors: new concepts and implications for cardiovascular therapeutics.
    Colucci WS; Braunwald E
    Cardiovasc Clin; 1984; 14(3):39-59. PubMed ID: 6144390
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta-blockers and hypertension.
    Cruickshank JM
    J Am Coll Cardiol; 2009 Jun; 53(22):2105-6; author reply 2106-7. PubMed ID: 19477369
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug treatment of high blood pressure.
    Hutchins LN
    Nurs Clin North Am; 1981; 16(2):365-76. PubMed ID: 6167937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of vasoactive substances in the treatment of cardiovascular diseases].
    Heine H; Schmidt H; Faulhaber HD; Anders G
    Dtsch Gesundheitsw; 1972 Nov; 27(44):2090-3. PubMed ID: 4405750
    [No Abstract]   [Full Text] [Related]  

  • 18. Are beta blockers effective first-line treatments for hypertension?
    Cayley WE
    Am Fam Physician; 2007 Nov; 76(9):1306-8. PubMed ID: 18019872
    [No Abstract]   [Full Text] [Related]  

  • 19. Doxazosin, an inferior antihypertensive agent?
    Furberg CD
    J Hum Hypertens; 2002 Jun; 16(6):375-7. PubMed ID: 12037690
    [No Abstract]   [Full Text] [Related]  

  • 20. Different metabolic effects of selective and nonselective beta-blockers rather than mere heart rate reduction may be the mechanisms by which beta-blockade prevents cardiovascular events.
    Fragasso G; Cera M; Margonato A
    J Am Coll Cardiol; 2009 Jun; 53(22):2105; author reply 2106-7. PubMed ID: 19477370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.